BioArctic AB (publ) Capital Reinvestment Ratio

Latest as of June 2026: 1.00x

BioArctic AB (publ) capital reinvestment ratio. BioArctic AB (publ) (BIOA-B) has a Capital Reinvestment Ratio of 1.00x as of June 2026, meaning it reinvests 1% of its operating cash flow (Skr137.84 Million) in capital expenditures (Skr137.84 Million). See BIOA-B cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.00x
Capex / Operating Cash Flow

Operating Cash Flow

Skr137.84 Million
SEK

Capital Expenditures

Skr137.84 Million
SEK

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of BioArctic AB (publ) (2016–2025)

Capital reinvestment ratio of BioArctic AB (publ) from 2016 to 2025. This chart tracks BioArctic AB (publ)'s Capital Reinvestment Ratio across 4 annual periods. See BioArctic AB (publ) (BIOA-B) flexibility index to measure the company's free cash flow as a share of total liabilities.

BioArctic AB (publ) Capital Reinvestment Ratio by Year (2016–2025)

BioArctic AB (publ) capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see BIOA-B cash flow metrics.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2025 0.01x Skr1.43 Billion Skr10.24 Million ▼ -70.2%
2023 0.02x Skr309.69 Million Skr7.44 Million ▲ +141.0%
2019 0.01x Skr327.17 Million Skr3.26 Million ▲ +126.9%
2016 0.00x Skr675.13 Million Skr2.97 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow